Company Profiles

driven by the PitchBook Platform

Pulse Therapeutics

Description

Operator of a medical device company. The company is focused on developing vascular drug delivery devices for blood clots in stroke patients.

2008

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$10M

Latest Deal Amount

$23.8M

Total Amount Raised

Description

Operator of a medical device company. The company is focused on developing vascular drug delivery devices for blood clots in stroke patients.

Website:

www.pulsetherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Devices and Supplies

Primary Office

911 Washington Avenue Suite 730 Saint Louis, MO 63101United States +1 (314) 787-7475
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Pulse Therapeutics's full profile, request a free trial.

    Pulse Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Pulse Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Pulse Therapeutics Investors (14)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Accelerate St LouisAccelerator/IncubatorMinority000 0000000 0000
    Billiken Angels NetworkAngel GroupMinority000 0000000 0000
    BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
    Central Illinois AngelsAngel GroupMinority000 0000000 0000
    Clifford HolekampAngel (individual)Minority000 0000000 0000
    Accelerate St Louis Accelerator/Incubator
    Billiken Angels Network Angel Group
    BioGenerator Not-For-Profit Venture Capital
    Central Illinois Angels Angel Group
    Clifford Holekamp Angel (individual)

    Pulse Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Sean MorrisChief Executive Officer
    Peggy StohrChief Financial Officer
    Francis Creighton Ph.DChief Technology Officer, President & Co-Founder
    Thomas HillmanExecutive Chairman
    Sean Morris Chief Executive Officer
    Peggy Stohr Chief Financial Officer
    Francis Creighton Ph.D Chief Technology Officer, President & Co-Founder
    Thomas Hillman Executive Chairman

    Pulse Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Eric Gulve Ph.DBioGeneratorPresident000 0000
    Stanley LynallOSF VenturesVice President of Venture Investments000 0000
    Thomas HillmanSelfExecutive Chairman000 0000
    William SchmidtCultivation CapitalManaging Partner, Life Sciences Fund000 0000
    Eric Gulve Ph.D President BioGenerator
    Stanley Lynall Vice President of Venture Investments OSF Ventures
    Thomas Hillman Executive Chairman Self
    William Schmidt Managing Partner, Life Sciences Fund Cultivation Capital
    Request full access to PitchBook